🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Collection of Blood for Multiple Collaborative Studies

Recruitingn/aAges 18 Years - anyAllUniversity of California, San Francisco
NCT01336855 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study seeks to confidentially collect blood from HIV-positive individuals and HIV-negative controls to provide basic scientists with specimens for collaborative studies.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * HIV-1 antibody negative with similar characteristics to HIV-1 positive cohort * HIV-positive subjects naive to antiretroviral therapy * HIV-positive subjects stable on or off antiretroviral therapy for a minimum of 6 months * Good venous access * Able to provide informed consent Exclusion Criteria: * Hemoglobin \< 9g/dl * Hematocrit \< 27% * Active treatment for cancer * Hospitalization or IV antibiotic use within the last 4 months * Immunosuppressive therapy within the last 4 months
💊

What it tests

  • Not listed
📍

Where

1 site
San Francisco General Hospital
San Francisco, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy